Sudo Kasumi, Ochiai Mariko, Aihara Naoyuki, Horiuchi Noriyuki, Yamamoto Atsushi, Matsumoto Sachiko, Oishi Koji
National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, 1-15-1 Tokura, Kokubunji, Tokyo 185-8511, Japan.
Laboratory of Veterinary Pathology, Azabu University, 1-17-71 Fuchinobe, Chuo-ku, Sagamihara, Kanagawa 252-5201, Japan.
J Toxicol Pathol. 2021 Apr;34(2):137-146. doi: 10.1293/tox.2020-0078. Epub 2021 Feb 25.
Batch safety tests (BSTs) of veterinary vaccines are conducted using small laboratory animals to assure the safety of vaccines according to several criteria, including clinical signs and change in body weight. Although the latter is used as an evaluation index in BSTs, there have been no reports on the internal changes that affect body weight during the test period. Therefore, we analyzed BST via pathological examination of the tested animals. Here, BSTs were performed for 176 batches using mice and 126 batches using of guinea pigs. Most of the gross findings could be classified into four lesion types (nodules, adhesions, ascites, no apparent signs), with only one vaccine inducing lesions that could not be classified into any of these four types. Histopathological examination revealed that the reactions caused by BST were pyogenic and/or granulomatous inflammation. Nodular or adhesive lesions comprised more severe pyogenic granulomatous inflammation than ascites or cases with no apparent gross lesions. These nodular or adhesive lesions were more frequently induced by vaccines that contained an adjuvant than by vaccines that did not contain an adjuvant. The cases with "exceptional" gross findings histologically presented severe necrosis of the hematopoietic system. Additional testing showed that these "exceptional" lesions were induced when a specific type of light liquid paraffin was injected along with other vaccine additives. Our results show that body weight loss and/or lesions during BST were induced by proinflammatory properties of the tested vaccines and that BST is a sensitive method for detecting unexpected effects of vaccine components.
兽用疫苗的批次安全性测试(BST)是使用小型实验动物进行的,以根据包括临床症状和体重变化在内的若干标准确保疫苗的安全性。尽管后者在BST中用作评估指标,但在测试期间,尚未有关于影响体重的内部变化的报道。因此,我们通过对受试动物进行病理检查来分析BST。在此,使用小鼠对176个批次进行了BST,使用豚鼠对126个批次进行了BST。大多数大体检查结果可分为四种病变类型(结节、粘连、腹水、无明显体征),只有一种疫苗诱导的病变无法归入这四种类型中的任何一种。组织病理学检查显示,BST引起的反应是化脓性和/或肉芽肿性炎症。结节性或粘连性病变比腹水或无明显大体病变的病例包含更严重的化脓性肉芽肿性炎症。与不含佐剂的疫苗相比,含佐剂的疫苗更常诱发这些结节性或粘连性病变。具有“特殊”大体检查结果的病例在组织学上表现为造血系统的严重坏死。进一步检测表明,当与其他疫苗添加剂一起注射特定类型的轻质液体石蜡时,会诱发这些“特殊”病变。我们的结果表明,BST期间的体重减轻和/或病变是由受试疫苗的促炎特性引起的,并且BST是检测疫苗成分意外作用的一种敏感方法。